pageInfo({
    time : "1261612638509"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USTRE5611SE20090702"
	        , headline : "Europe biotechs see light at end of funding tunnel"
	        , keywords : "[Pharmaceuticals - generic and speciality, Pharmaceuticals - diversified, Western Europe, Europe, Regulation and enforcement, Online Report text item, \"New issues of shares, bonds and other financial instruments\", Biotechnology, Pharmaceuticals (sub-industry), Switzerland, Initial Public Offerings, Equities, Australia, Asia, United States of America, Central and Eastern Europe, Art, Hobbies, Canada]"
	        , tickers : "[xa;NFND, de;DNR, de;DNRF, de;DNRS, de;DNRX, de;S3F, de;S3FF, de;S3FS, de;UR9, de;UR9F, de;UR9X, SANN.S, us;CLVL, us;DNDN, de;B4XX, de;B4XS, ARPN.S, au;CUV, BSLN.S, BXLN.S, ch;ARP, ch;BSL, ch;BXL, ch;CYT, ch;NOV, ch;SANN, CYTN.S, de;B4X, de;B4XF, ADXN.S]"
	    }
	    , channel : {
	        id : "21"
	        , name : "innovationNews"
	        , title : "Deals"
	    }})